Tag: esophagus

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsEsophagus

Solventum Announces Launch of Secondary Offering of Common Stock

Employment BOOST Launches Comprehensive Leadership Coaching Program Integrating 360° Feedback and Industry-Leading Curriculum

The Gross Law Firm Notifies Shareholders of Neogen Corporation(NEOG) of a Class Action Lawsuit and an Upcoming Deadline

Tag: esophagus

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us